Log in
Enquire now
Mogrify

Mogrify

Mogrify is developing tailored cellular conversions that power future cell therapies.

OverviewStructured DataIssuesContributors

Contents

mogrify.co.uk
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Healthcare
Healthcare
Drug discovery
Drug discovery
Technology
Technology
Biotechnology
Biotechnology
Biology
Biology
‌
Deep Tech
Health technology
Health technology
...
Location
United Kingdom
United Kingdom
Cambridge, Cambridgeshire
Cambridge, Cambridgeshire
0
Milton, West Dunbartonshire
Milton, West Dunbartonshire
B2X
B2B
B2B
0
CEO
‌
DR. DARRIN M. DISLEY OBE
0
Number of Employees (Ranges)
51 – 2000
Email Address
info@mogrify.co.uk
Full Address
25 Cambridge Science Park Milton Rd, Milton, Cambridge, Cambridgeshire CB4 0FW, GB
Investors
Parkwalk Advisors
Parkwalk Advisors
Jonathan Milner
Jonathan Milner
Darrin M Disley
Darrin M Disley
Astellas Venture Management
Astellas Venture Management
University of Bristol Enterprise Fund
University of Bristol Enterprise Fund
Ahren Innovation Capital
Ahren Innovation Capital
24Haymarket
24Haymarket
Founded Date
2019
0
Total Funding Amount (USD)
84,500,000
Latest Funding Round Date
October 2, 2023
Competitors
Bit.bio
Bit.bio
Glassdoor ID
3147233
Latest Funding Type
Series A
Series A
COO
‌
Joe Foster
Country
United Kingdom
United Kingdom
0
Headquarters
Cambridge, Cambridgeshire
Cambridge, Cambridgeshire

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
10,000,000
Public/Private
Private0

Mogrify has developed a proprietary direct cellular conversion technology, which makes it possible to transform (transmogrify) any mature human cell type into any other without going through a pluripotent stem cell- or progenitor cell-state.

In a collaboration with Sangamo, Mogrif’s cell conversion technology will be applied to generate regulatory T cells (Tregs) from pluripotent stem cells and embryonic stem cells. Sangamo aims to apply its ZFP gene engineering technology to Tregs as allogeneic cell therapies to treat inflammatory and autoimmune diseases.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Mogrify

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.